Form 4 for PCSA Processa Pharmaceuticals, Inc.
Accepted 2023-07-24 00:00:00 ET · period of report 2023-06-27 · accession 0000897069-23-001000 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-24 | 2023-06-27 | PCSA | Baluch Khoso | Dir | M - OptEx | — | +15.5K | 28.0K | +124% | — |
| D | 2023-07-24 | 2023-06-27 | PCSA | Baluch Khoso | Dir | M - OptEx | $0.00 | -15.5K | 0 | -100% | $0 |
| D | 2023-07-24 | 2023-06-27 | PCSA | Baluch Khoso | Dir | A - Grant | $0.00 | +101.4K | 101.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-27 | M | A | 15,455 | — | 27,955 | D | — | — | (F1) Vesting of time-based restricted shares. |
| 2 | Derivative | Restricted Stock | 2023-06-27 | M | D | 15,455 | $0.00 | 0 | D | $0.00 · — to — | 15,455 Common Stock | (F1) Vesting of time-based restricted shares. |
| 3 | Derivative | Restricted Stock | 2023-06-27 | A | A | 101,365 | $0.00 | 101,365 | D | $0.00 · — to — | 101,365 Common Stock | (F2) The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders. |